Provided by Tiger Trade Technology Pte. Ltd.

Lyra Therapeutics

1.52
-0.3000-16.48%
Pre-market: 1.520.0073+0.48%08:00 EST
Volume:100.34K
Turnover:165.44K
Market Cap:2.70M
PE:-0.07
High:1.83
Open:1.83
Low:1.51
Close:1.82
52wk High:37.50
52wk Low:1.51
Shares:1.77M
Float Shares:1.32M
Volume Ratio:3.08
T/O Rate:7.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-22.9324
EPS(LYR):-71.7474
ROE:-404.48%
ROA:-33.08%
PB:-0.62
PE(LYR):-0.02

Loading ...

Lyra Therapeutics Faces Nasdaq Delisting After Becoming Shell

TIPRANKS
·
Feb 07

Lyra Therapeutics common stock to be delisted by Nasdaq

TIPRANKS
·
Feb 07

Nasdaq Moves to Delist Lyra Therapeutics Over Public Shell Status and Equity Shortfall

Reuters
·
Feb 07

Top Midday Decliners

MT Newswires Live
·
Jan 13

Gold Rises Sharply; Lyra Therapeutics Shares Plunge

Benzinga_recent_news
·
Jan 13

BUZZ-U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver miners

Reuters
·
Jan 12

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:24 AM

Reuters
·
Jan 12

BUZZ-Lyra Therapeutics plunges after halting development of lead nasal drug

Reuters
·
Jan 12

BRIEF-Lyra Therapeutics Inc - Terminates CEO Maria Palasis And CFO Jason Cavalier - SEC Filing

Reuters
·
Jan 12

Lyra Therapeutics Suspends LYR-210 Development and Reduces Workforce

Reuters
·
Jan 12

Lyra Therapeutics Provides Corporate Update

THOMSON REUTERS
·
Jan 12

Lyra Therapeutics Inc: Expects Lyra's Cash Runway to Last Into Q3 of 2026

THOMSON REUTERS
·
Jan 12

Lyra Therapeutics Inc: Workforce Reduction Impacting Its Remaining 28 Employees

THOMSON REUTERS
·
Jan 12

Lyra Therapeutics Inc - Suspends Development of Lyr-210

THOMSON REUTERS
·
Jan 12

NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM

Reuters
·
Jan 12

Perceptive Advisors LLC Disposes of Lyra Therapeutics Inc. Common Shares

Reuters
·
Nov 14, 2025

Lyra Therapeutics Q3 EPS $(3.38) Beats $(5.25) Estimate, Sales $25.000K Miss $195.000K Estimate

Benzinga
·
Nov 13, 2025

Lyra Therapeutics Q3 net loss narrows

Reuters
·
Nov 13, 2025

Lyra Therapeutics Inc Q3 Net Loss per Share $3.38

THOMSON REUTERS
·
Nov 13, 2025

Perceptive Advisors LLC Reports Sale of Lyra Therapeutics Inc. Common Shares

Reuters
·
Nov 11, 2025